The US Food and Drug Administration (FDA) has approved the first prescription medicine for adults with moderate-to-severe obstructive sleep apnea (OSA): the weight-loss drug Zepbound. Zepbound may ...

The US Food and Drug Administration on Friday approved the first prescription medicine for obstructive sleep apnea: the weight-loss drug Zepbound. The medicine, part of the class known as GLP-1 ...

NEW YORK (Reuters Health) - Men with sleep apnea are more likely to stick with their overnight treatment if their wives stay in bed with them rather than flee their snoring, a small study suggests. In ...

Averaging up to 20% of weight loss, adults taking Zepbound had at least 25 fewer breathing interruptions each hour as they slept Up to 50% of adults taking Zepbound no longer had symptoms associated ...

A popular obesity drug may help treat a dangerous disorder in which people struggle to breathe while they sleep, a new study finds. Tirzepatide, the medication in the weight loss drug Zepbound and ...

The weight loss drug Zepbound has become the first prescription medication approved to treat obstructive sleep apnea. The Food and Drug Administration on Friday authorized the use of Zepbound, made by ...

Zepbound is the first prescription drug approved specifically to treat the common condition. By Dani Blum The Food and Drug Administration on Friday approved the weight loss drug Zepbound to treat ...